Cencora (COR)Executive Vice President sold ~$537K
Elizabeth S Campbell, Executive Vice President at Cencora, sold ~$537K of Cencora shares.
- ~$537K
- Approx. value · 2,000 sh @ $268.28
- 15K
- Holds after · shares reported
- Traded
- Mar 24, 2025
- Filed
- Mar 26, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 6, 2025Insider · 1 personInsiders: 2 sales (~$314.5M)
- Feb 21, 2025InsiderOfficer sold ~$1.21M of COR shares in the open market
- Feb 27, 2025Insider · 1 personInsiders: 2 sales (~$3.7M)
- Mar 3, 2025Insider · 1 personInsiders: 2 sales (~$1.3M)
- Mar 10, 2025InsiderOfficer sold ~$520K of COR shares in the open market
- Mar 18, 2025Insider · 1 personInsiders: 2 sales (~$1.3M)
- Mar 24, 2025 · this disclosureInsiderOfficer sold ~$537K of COR shares in the open market
What came next
- Mar 24, 2025FDARecall: Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30 Unit Dose per carton), Rx only, Distributed by: Amer…
- Mar 24, 2025InsiderOfficer sold ~$571K of COR shares in the open market
- Mar 25, 2025Insider · 1 personInsiders: 2 sales (~$3.9M)
- Mar 27, 2025CongressDisclosed sale of COR — reported range $15,001 - $50,000
- Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 100 mg/mL*, 1 x 1 mL Single-Dose Vial, Rx only, Manufactured by: Somerset Therapeutics Limited, #54/1, Boodhihal Village, Nela…
- Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 100mg/mL*, 5 x 1 mL Single-Dose Vials, Rx Only, Manufactured by: Somerset Therapeutics Limited, #54/1 Boodhihal Village, Nelam…
- Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somerset Therapeutics Limited, 54/1, Boodhihal Village, Nelamangala…
- Apr 21, 2025InsiderCEO sold ~$1.44M of COR shares in the open market
- Apr 22, 2025InsiderChair sold ~$4.11M of COR shares in the open market
- May 12, 2025CongressDisclosed sale of COR — reported range $50,001 - $100,000
- May 14, 2025InsiderDirector sold ~$837K of COR shares in the open market
- May 15, 2025FDARecall: Indomethacin Extended-Release Capsules, USP, 75 mg, 30 capsules (3 x 10 blister cards) per carton, Rx Only, Distributed by: American Health Packaging, Columbus…
- May 19, 2025InsiderCEO sold ~$1.45M of COR shares in the open market
- May 20, 2025InsiderChair sold ~$4.28M of COR shares in the open market
- May 29, 2025Insider · 1 personInsiders: 2 sales (~$867K)
- Jun 18, 2025Insider · 2 peopleInsiders: 2 sales (~$2.7M)
- Jun 24, 2025InsiderChair sold ~$4.27M of COR shares in the open market
- Jul 18, 2025InsiderCEO sold ~$1.46M of COR shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Cencora
For Cencora, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 1 Congress trade report, 29 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COR page.
Other recent filings by Elizabeth S Campbell, Executive Vice President
- SEC Form 4 at Cencora (COR)Aug 26, 2026
- SEC Form 4 at Cencora (COR)Dec 23, 2025
- SEC Form 4 at Cencora (COR)Oct 4, 2025
- SEC Form 4 at Cencora (COR)Mar 26, 2025
The full history of Elizabeth S Campbell, Executive Vice President is on the profile page.
How this filing works
Other disclosures at Cencora
- SEC Form 4Oct 5, 2026
- SEC Form 4Sep 17, 2026
- SEC Form 144Sep 16, 2026
- SEC Form 144Sep 11, 2026
- SEC Form 144Sep 4, 2026
- SEC Form 4Sep 3, 2026
Everything OQRO holds on this company is on its COR page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
